HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Pramoxine

HCID 4886
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
140-65-8
Standard SMILES
CCCCOc1ccc(OCCCN2CCOCC2)cc1
InChIKey
DQKXQSGTHWVTAD-UHFFFAOYSA-N
Molecular formula
C17H27NO3
Average molar mass
293.4 g/mol
Monoisotopic mass
293.19909372

Overview

Pramocaine is a member of the class of morpholines that is morpholine substituted at the nitrogen atom by a 3-(4-butoxyphenoxy)propyl group. It has a role as a local anaesthetic. It is an aromatic ether and a member of morpholines.

Names & identifiers

Preferred name
Pramoxine
IUPAC
4-[3-(4-butoxyphenoxy)propyl]morpholine
English name
pramocaine
Molecular formula
C17H27NO3
Molecular weight
293.4

Names & synonyms

Pramocainepramoxine140-65-8Proxazocain4-[3-(4-Butoxyphenoxy)propyl]morpholinepramocainumPramocaina4-(3-(p-Butoxyphenoxy)propyl)morpholinep-Butoxyphenyl gamma-morpholinopropyl ethergamma-Morpholinopropyl 4-n-butoxyphenyl ether4-(3-(4-butoxyphenoxy)propyl)morpholineCHEBI:8357
Show more names
PramoxinTronoteneTronothane4-[3-(4-Butoxyphenoxy)propyl]morphorine4-(3-(4-BUTOXYPHENOXY)PROPYL)-MORPHOLINEMorpholine, 4-[3-(4-butoxyphenoxy)propyl]-
068X84E056DTXSID8040692RefChem:55901DTXCID6020692C05AD07D04AB07205-425-7Tronopthane

Database identifiers

CAS
140-65-8
PubChem CID
4886
DTXSID
DTXSID8040692
ChEMBL
CHEMBL1198
ChEBI

Properties

Computed structural properties

XLogP
3.1
Topological polar surface area
30.9 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
9
Heavy atoms
21
Formal charge
0
Complexity
248

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP3.56
Human DrugsPharmaceuticals
Collision Cross Section177.42 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Boiling point
6 · bp6 196°; bp2.8 183-184°
Density
1.0112 · 1.0112 (rough estimate)
refractive index
1.542 · 1.5420 (estimate)
pka
7.18 · 7.18±0.10(Predicted)
Water Solubility
3.574 mg/L · 3.574mg/L(22.5 ºC)
CAS DataBase Reference
140 · 140-65-8
FDA UNII
68 X84E056 · 068X84E056
ATC code
5 AD07,D04AB07 · C05AD07,D04AB07
Symbol(GHS)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS ClassificationNot Classified

Hazard information

Hazard Classes and CategoriesNot Classified

Safety data

Toxicity
LD50 in mice (mg/kg): 300 i.p., 900 s.c. (Monash, Gibbs)
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 4 items

C - Cardiovascular system

D - Dermatologicals

QC - Cardiovascular system

QD - Dermatologicals

PharmacodynamicsPramocaine temporarily relieves pain, pruritis, burning and discomfort associated with minor lip and skin irritations and hemorrhoid's by inhibiting voltage gated sodium channels on neurons.
Mechanism of Action · 1 item

Pramocaine reversibly binds and inhibits voltage gated sodium channels on neurons decreasing sodium permeability into the cell. This stabilizes the membrane and prevents ionic fluctuations needed for depolarization stopping any action potential propagation.

MeSH Pharmacological Classification · 1 item

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Absorption, Distribution and ExcretionThere is minimal absorption after topical administration and it is not given orally.

Uses & manufacturing

Use ClassificationPharmaceuticals

Applications

UsesAnesthetic (topical).

Upstream & downstream products

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEBI:8357
UNII
068X84E056
EC Number
205-425-7
Nikkaji
J5.793B
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
280 · P280-P305+P351+P338
Toxicity
50 in · LD50 in mice (mg/kg): 300 i.p., 900 s.c. (Monash, Gibbs)

Upstream raw materials

Hydrochloric acid4-ButoxyphenolPotassium hydroxide

Suppliers14 total

北京华美互利生物化工010-56205725 · [email protected]
广州隽唐科技有限公司020-36607679 13502246435 · [email protected]
山东利腾生物科技有限公司+86-18663721413 +86-15552573001 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
陕西缔都医药化工有限公司029-029-81120477 17792793610 · [email protected]
上海药禾平生物医药科技有限公司57540919 13120888836 · [email protected]
BOC Sciences16314854226 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
上海相辉医药科技有限公司13611835272 13611835272 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
合肥钼凯医药科技有限公司18001872185; 18001872185 · [email protected]
山东碳氢生物化工有限公司13060081947 13060081947 · [email protected]

Additional notes

DefinitionChEBI: A member of the class of morpholines that is morpholine substituted at the nitrogen atom by a 3-(4-butoxyphenoxy)propyl group.